http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#head
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#provenance
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/3439
http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0019196
http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#provenance
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://purl.org/dc/terms/description
[To determine whether baseline LDL or HDL levels and statin use affect SVR rates, we retrospectively evaluated the IDEAL (Individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) trial, in which 3070 treatment-naive, hepatitis C virus (HCV) genotype 1-infected patients were treated for up to 48 weeks in one of the following arms: (1) peginterferon (PEG-IFN) alfa-2b at 1.5 microg/kg/week with ribavirin (RBV) at 800 to 1400 mg/day, (2) PEG-IFN alfa-2b at 1.0 microg/kg/week with RBV at 800 to 1400 mg/day, or (3) PEG-IFN alfa-2a at 180 microg/week with RBV at 1000 to 1200 mg/day.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/20568303
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/dc/terms/created
2017-10-17T13:13:35+02:00
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0